Andrea Moran-Costoya
Overview
Explore the profile of Andrea Moran-Costoya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bauza-Thorbrugge M, Amengual-Cladera E, Galmes-Pascual B, Moran-Costoya A, Gianotti M, Valle A, et al.
Nutrients
. 2024 Sep;
16(18).
PMID: 39339665
Obesity and type 2 diabetes mellitus are global public health issues. Although males show higher obesity and insulin resistance prevalence, current treatments often neglect sex-specific differences. White adipose tissue (WAT)...
2.
Martinez-Cignoni M, Gonzalez-Vicens A, Moran-Costoya A, Amengual-Cladera E, Gianotti M, Valle A, et al.
Free Radic Biol Med
. 2024 Sep;
224:574-587.
PMID: 39241985
Estrogens have a well-known protective role in the development of the metabolic syndrome. Nevertheless, recent epidemiological data question the cardioprotective effect of estrogens in obese and diabetic women. In this...
3.
Amengual-Cladera E, Morla-Barcelo P, Moran-Costoya A, Sastre-Serra J, Pons D, Valle A, et al.
Biology (Basel)
. 2024 May;
13(5).
PMID: 38785784
Metformin, a widely used anti-diabetic drug, has garnered attention for its potential in cancer management, particularly in breast and colorectal cancer. It is established that metformin reduces mitochondrial respiration, but...
4.
Martinez-Cignoni M, Gonzalez-Vicens A, Moran-Costoya A, Proenza A, Gianotti M, Valle A, et al.
Int J Mol Sci
. 2021 Dec;
22(24).
PMID: 34948369
It has been reported that 17β-estradiol (E2) can exert beneficial effects against the development of obesity, providing women with a healthier metabolic profile and conferring cardiovascular protection. However, a growing...
5.
Moran-Costoya A, Proenza A, Gianotti M, Llado I, Valle A
Antioxid Redox Signal
. 2021 Mar;
35(9):753-774.
PMID: 33736456
Nonalcoholic fatty liver disease (NAFLD) is a hepatic and systemic disorder with a complex multifactorial pathogenesis. Owing to the rising incidence of obesity and diabetes mellitus, the prevalence of NAFLD...
6.
Galmes-Pascual B, Martinez-Cignoni M, Moran-Costoya A, Bauza-Thorbrugge M, Sbert-Roig M, Valle A, et al.
Free Radic Biol Med
. 2020 Feb;
150:148-160.
PMID: 32105829
The prevalence and severity of nonalcoholic fatty liver disease (NAFLD) is higher in men and postmenopausal women compared to premenopausal women, suggesting a protective role for ovarian hormones. Diet-induced obesity...